CRISPR-based platforms for detecting tumor-associated genetic materials in clinical samples

Area of Science:

• Biotechnology
• Molecular Biology
• Cancer Research

Background:

• Traditional tumor detection methods are complex, time-consuming, and costly.
• Tumor-associated genetic markers are crucial for early cancer detection and monitoring.
• CRISPR/Cas systems present a promising alternative for molecular diagnostics.

Purpose of the Study:

• To critically discuss advancements in CRISPR/Cas systems for detecting tumor-associated genetic materials.
• To highlight the significance of these genetic materials in cancer diagnosis and prognosis.
• To explain the key concepts of CRISPR/Cas systems in tumor detection.

Main Methods:

• Review and critical discussion of CRISPR/Cas-based detection strategies.
• Analysis of CRISPR/Cas applications for gene mutations, DNA methylation, miRNA, lncRNA, and circRNA.
• Explanation of CRISPR/Cas system mechanisms for tumor marker detection.

Main Results:

• CRISPR/Cas systems demonstrate high targeting specificity and signal amplification for genetic material detection.
• Breakthroughs achieved in detecting various tumor-associated genetic materials using CRISPR/Cas.
• CRISPR/Cas systems offer programmability and rapid reaction times.

Conclusions:

• CRISPR/Cas systems are emerging as powerful tools for tumor detection, surpassing traditional methods.
• The application of CRISPR/Cas in detecting diverse tumor genetic markers shows significant potential.
• Understanding CRISPR/Cas mechanisms is key to advancing cancer diagnostics and prognostics.